Basics Bicycle Therapeutics plc IPO Date: May 20, 2019 Sector: Healthcare Industry: Biotech Market Cap: $449.5M Activated in VL: True Average Daily Range Avg Daily Range: $0.61 | 2.98% Avg Daily Range (30 D): $0.26 | 3.25% Avg Daily Range (90 D): $0.19 | 2.42% Institutional Daily Volume Avg Daily Volume: .21M Avg Daily Volume (30 D): .3M Avg Daily Volume (90 D): .26M Trade Size Avg Trade Size (Sh.): 91 Avg Trade Size (Sh.) (30 D): 78 Avg Trade Size (Sh.) (90 D): 79 Institutional Trades Total Inst.Trades: 1,042 Avg Inst. Trade: $2.02M Avg Inst. Trade (30 D): $1.57M Avg Inst. Trade (90 D): $1.53M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.19M Avg Closing Trade (30 D): $1.34M Avg Closing Trade (90 D): $1.34M Avg Closing Volume: 46.3K     News Aug 29, 2025 @ 7:49 AM Bicycle Toxin Conjugates Clinical Trials FDA Appro... Source: Globe Newswire Aug 27, 2025 @ 12:00 PM Maxion Therapeutics Strengthens Board with Appoint... Source: Maxion Therapeutics Mar 3, 2025 @ 6:00 PM Advanced Urothelial Carcinoma Clinical Trial Pipel... Source: Delveinsight Jun 27, 2024 @ 1:40 PM Are Medical Stocks Lagging Bicycle Therapeutics (... Source: Zacks Equity Research Jun 21, 2024 @ 12:24 PM Top 5 Small-Cap Biotechnology Stocks for a Stable ... Source: Nalak Das Financials   TTM Q3 2025 Q2 2025 Basic EPS $-3.62 $-.85 $-1.14 Diluted EPS $-3.62 $-.85 $-1.14 Revenue $ 28.34M $ 11.73M $ 2.92M Gross Profit $ $ $ Net Income / Loss $ -250.66M $ -59.1M $ -78.95M Operating Income / Loss $ -290.02M $ -65.55M $ -86.6M Cost of Revenue $ $ $ Net Cash Flow $ -241.78M $ -71.88M $ -73.33M PE Ratio